Summit Therapeutics Inc. Share Price
NASDAQ: SMMT | Large CapSummit Therapeutics Inc. Stock Performance
Summit Therapeutics Inc. Share Price Today
As of 30 October 2026, Summit Therapeutics Inc.'s share price is $15.97. The stock opened at $15.81, compared to its previous close of $15.77. During today's trading session, Summit Therapeutics Inc.'s share price traded between $15.79 and $16.54, with an average price of $16.16. Over the past 52 weeks, the stock has recorded a high of $29.21 and a low of $12.07. In terms of performance, Summit Therapeutics Inc.'s share price has declined by 25.60% over the last six months and is down 15.50% on a year-on-year basis.
Summit Therapeutics Inc. Share Price Chart
Summit Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
Summit Therapeutics Inc. Annual Profit & Loss
All figures in USD
About Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Summit Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $16.85 | $16.05 | -5.20% |
Sep 2026 | $13.47 | $16.93 | +18.10% |
Aug 2026 | $13.07 | $14.34 | +10.14% |
Jul 2026 | $14.54 | $13.02 | -10.64% |
Jun 2026 | $16.72 | $14.57 | -16.89% |
May 2026 | $16.02 | $17.53 | -18.33% |
Apr 2026 | $19.17 | $21.46 | +13.27% |
Mar 2026 | $16.16 | $18.95 | +14.16% |
Feb 2026 | $14.24 | $16.60 | +14.72% |
Jan 2026 | $17.66 | $14.47 | -17.29% |
Dec 2025 | $17.36 | $17.50 | -2.15% |
Nov 2025 | $18.86 | $17.88 | -5.40% |